⌕
Opko Health · OPK · Nasdaq
Tenet 43 · Weak
Compare
$1.62−3.57%At closeTenet 43 · Weak
$1.62−0.06 (−3.57%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Opko Health (OPK) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 66% below its peak, net margin −37.2%. Worth your attention in FY25: Share count (+10.2%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼14.9%
606.9
FY21→FY25CAGR −23.5%/yr
Net income ($M)▼324.0%
−225.7
one-off year: see footnoteCAGR —
Free cash flow ($M)▲8.5%
−190.8
FY21→FY25CAGR —
Diluted EPS▼275.0%
−0.30
no value for 2 of 5 yearsCAGR —
What the receipts whisper · what a headline number hides
Share count
+10.2%

681.5mn → 751.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$12.3M

−50.9% YoY in FY25 · 2.0% of revenue.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)606.9Revenue−400.9COGS205.9Gross profit−124.0R&D−223.0SG&A−117.4Op income−108.3Tax & other−225.7Net income

-37¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
403020100%sector median net margin ~4%FY21FY25

Over this window: gross 32.8% → 33.9%. Net margin -37.2% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
596.9606.9713.1863.51,004.21,774.7▼14.9%−23.5%
Cost of revenue
350.2400.9494.6545.4716.01,193.2▼18.9%−23.9%
Gross profit
246.7205.9218.5318.1288.2581.5▼5.8%−22.9%
Research & development
127.6124.0105.289.673.976.8▲17.9%+12.7%
Selling, general & admin
208.4223.0304.2300.6372.7468.9▼26.7%−17.0%
Total operating expenses
292.8323.3370.6475.1514.5562.8▼12.7%−12.9%
Operating incomefeeds ROC rank
−46.1−117.4−152.1−157.0−226.318.8▲22.8%—
Other income, net
−30.6−124.0141.7−27.3−165.3−32.8——
Pretax income
−76.7−241.4−10.4−184.3−391.5−14.0▼2229.3%—
Income tax
−6.2−15.742.84.4−63.515.5——
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−148.1−225.7−53.2−188.9−328.4−30.1▼324.0%—
Per share
Diluted EPSbuyback-sensitive
−0.19−0.30−0.08−0.25——▼275.0%—
Diluted shares (mn)
746.48751.13694.02751.77772.65681.46▲8.2%+2.5%
Margins
Gross margin18th pct in Healthcare
41.3%33.9%30.6%36.8%28.7%32.8%▲3.3pp+1.2pp
Operating margin
−7.7%−19.3%−21.3%−18.2%−22.5%1.1%▲2.0pp−20.4pp
Net margin18th pct in Healthcare
−24.8%−37.2%−7.5%−21.9%−32.7%−1.7%▼29.7pp−35.5pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was −110% vs a −2% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 16% vs a −2% norm for this window, likely a one-time item; see the filing.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Opko Health's revenue last fiscal year?

Opko Health reported revenue of $606.9M in fiscal 2025, down 14.9% from fiscal 2024.

What was Opko Health's net income?

Opko Health reported net income of −$225.7M in fiscal 2025, a net margin of −37.2%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.